Targeted Strategies for Today's Evolving Markets

MissionIR Blog

The Alkaline Water Co. (WTER) Reports Revenue Jump of 78% for Nine Months Ended December 31, 2016

Expanded distribution to 36 more of the top national grocery retailers propelled The Alkaline Water Company, Inc. (OTCQB: WTER) to reach revenues of $8,927,976 for the nine months ended December 31, 2016. This represents an increase of 78% compared to $5,010,547 generated during the same period in 2015. For its third quarter ended December 31, 2016, sales were $2,973,689, a 67% increase from its sales of $1,777,701 for the same period in 2015. The company is in the bottled water industry. Its fiscal year ends March 31.

For both periods, the company sharply cut its losses. For the three months ended December 31, 2016, the net loss was $498,374, compared to its loss of $1,094,721 during the same period in 2015. For the nine months ended December 31, 2016, the net loss was $2,787,681, compared to the net loss of $3,644,028 during the same period in 2015.

In its February 14, 2017, SEC 10-Q filing (http://dtn.fm/aHu7g), The Alkaline Water Company, Inc., stated that its jump in revenues for the three and nine months ended December 31, 2016, was attributed to the increase in its distribution. In both 2016 and 2015 periods ending on December 31, the company’s products were available in all 50 states. However, for the year ended March 31, 2016, its water products were in 25,000 retail locations instead of just 20,000 the prior year. That increased distribution, the company reported to the SEC, generated the increased revenues for the most recent three- and nine-month periods ended December 31, 2016.

In the SEC filing, the company said that it sells to customers including the food chains of Albertson’s, Safeway, Kroger, Jewel-Osco and more. It also sells to convenience stores and natural foods product stores, the filing stated. It sold direct to large national distributors. In both the three-month and nine-month periods ended December 31, 2016, the company’s increased volume meant that its gross profit rate increased, as it was able to buy raw materials in larger volume from its suppliers. As a result, its losses for both the three months and nine months ended December 31, 2016, were reduced.

In the 10-Q, The Alkaline Water Company, Inc., reported that it had entered, on February 1, 2017, a $3 million, three-year, revolving credit agreement with SCM Specialty Finance Opportunities Fund, L.P. It has drawn $686,080.94 on that financial revolver to pay off the amount it borrowed earlier from Gibraltar Business Capital, LLC. Of the total, $628,782.94 was used to pay off the Gibraltar debt, and the remaining monies paid closing costs.

For more information, visit www.TheAlkalineWaterCo.com

Posted in Small Cap News | Leave a comment

Golden Entertainment, Inc. (NASDAQ: GDEN) Set to Capitalize on the Immensity of the US Gambling Market

Billions of dollars are generated from the U.S. gambling market each year. Despite a new movement toward online gambling, especially in the United Kingdom, physical brick and mortar casinos are still dominating in terms of revenue.

A political aspect that could impact the casino industry in the U.S. is the election of Donald Trump. Although moral issues still surround the market, the new president has close affiliations with the casino industry. In 2015, gross gaming revenue (GGR) came in at over 40%, but in 2016, according to CasinoNewsDaily.com (http://dtn.fm/r1Qjq), the U.S. was at the top of the full-year losses chart, the number representing the amount staked by gambling customers minus payouts.

According to InvestmentWatchBlog.com (http://dtn.fm/Qfro6), the casino annual growth rate in Nevada came in at 4.5% between 2011 and 2015, with a market growth during that period of 7.3%. Despite it not being known how much revenue makes up the online casino industry compared to the brick and mortar casino industry, slots make up 50% of gaming revenue in Nevada.

Golden Entertainment, Inc. (NASDAQ: GDEN), the largest branded tavern operator in Nevada and a market leader in distributed gaming, is set to capitalize on the immensity of the U.S. gambling market through its robust development and acquisition pipeline, which included the acquisitions of C. Lohman Games, Inc. in January 2016, and Amusement Services, LLC in April of the same year. The company now has over 10,000 devices in over 1,000 locations across the United States, including Pahrump Nugget Hotel & Casino, Gold Town Casino, and Lakeside Casino & RV Park, all of which are in Nevada.

Golden Entertainment has multiple paths to achieve meaningful growth. For 2017, the company has seven new taverns under development with a robust pipeline of new-build sites. The company plans to acquire smaller distributed gaming operators that lack the scale to compete in profitability, as well as regional casino assets, and also to reinvest in existing casino properties, such as its Rocky Gap and Pahrump facilities.

Golden Entertainment currently owns rights to potential distributed gaming locations and aims to pioneer new distributed gaming jurisdictions across the country. Additionally, by merging with public gaming operators, the company is offering the potential for increased liquidity to shareholders.

For more information, visit www.GoldenEnt.com

Posted in Small Cap News | Leave a comment

Vertex Energy, Inc. (NASDAQ: VTNR) Enters into $30 Million Credit Refinancing

Vertex Energy, Inc. (NASDAQ: VTNR) announced on February 8, 2017, that it has reached an agreement with Encina Business Credit, LLC (EBC) for a $30 million credit refinancing, including a funded term note, a draw term loan, and a revolving line of credit. The company indicated that the funds will be used to retire debt and for working capital.

Vertex Energy, Inc., refines and markets high quality hydrocarbon products. It filed an 8-K with the SEC on February 7, 2017, defining the new credit facility from EBC.

“The refinance of the company’s prior credit facility reflects our belief in the future growth of the company,” said Benjamin P. Cowart, CEO of Vertex. “We believe that this step was necessary in ensuring that we clean up our balance sheet, which includes paying off both of our prior lenders, consolidating our debt into one facility and strengthening our cash position.”

EBC is an asset-based lender specializing in middle market borrowers. Its revolving lines of credit and term loans range from $5 million to $50 million. It lends to both public and private companies. Positive cash flow is not required.

Cowart added that Vertex Energy is positioned to grow its business in 2017.

“With the financing completed, we were able to close on the acquisition on the assets of a small collection company in Louisiana. With approximately 90 million gallons of processing capacity, we believe that our collections vertical is key to our growth,” he said.

The company anticipates growing its self-collected gallons from some 20% of overall production to 25% in 2017, he added.

The SEC 8-K filing detailed the arrangements with EBC. It stated that $12 million was loaned to Vertex by EBC on February 1, 2017, and an additional $8 million may be loaned from time to time, under the new credit agreement. The other $10 million will be made available by EBC to Vertex under a revolving credit agreement formula, including ‘eligible’ inventory. The revolving credit agreement terminates on February 1, 2020, when any unpaid amounts and interest are due, the filing states.

Vertex Energy, Inc. stated that its use of revolving credit funds would be for working capital, capital expenditures and to refinance existing credit obligations. The company used $11,282,537 for that purpose. As of the filing date, the company had borrowed $12 million of the EBC credit agreement and $884,000 under the revolving credit agreement.

For more information, refer to www.VertexEnergy.com

Posted in Small Cap News | Leave a comment

National Waste Management Holdings, Inc. (NWMH) Continues to Grow Thanks to Three-Pronged Approach to Business Strategy

Based in Florida, National Waste Management Holdings, Inc. (OTC: NWMH) is a growing waste management company providing compliant and comprehensive solutions for waste management. The company has created long-term partnerships with a variety of customers from multiple sectors, including municipal, commercial, industrial, and institutional.

NWMH operates based upon a three-pronged approach: acquiring complementary businesses in Florida, Upstate New York and surrounding areas; expanding its presence across the United States; and increasing its operational efficiency with both its existing clients and any future acquisitions.

In Florida, the company is currently covering Marion, Citrus, Hernando, Lake, Levy, Sumter, Pinellas, Pasco and Hillsborough Counties. National Waste Management Holdings has been showing impressive growth with an aggressive acquisition strategy, acquiring and restructuring existing “mom and pop type” facilities in Florida and neighboring counties, but also in Kingston, NY, and the surrounding areas in Upstate New York.

National Waste Management Holdings completed its acquisition of a permitted waste processing and disposal facility, Waste Recovery Enterprises, LLC, in Bainbridge, NY, for $250,000 and 2.75 million restricted shares of the company’s common stock. Waste Recovery also offers commercial and residential garbage collection and roll-off services, with plans to expand service offerings to include recycled cardboard and paper shredding operations. In addition to the above, the company recently closed its acquisition of Northeast Data Destruction and Recycling, and it has three acquisitions actively in negotiation, with plans to execute letters of intent for each entity by the end of February, including a construction and demolition (C&D) and class III transfer station in New Port Richey, FL, and a recycling facility in Lakeland, FL.

The company plans to continue enhancing its geographic footprint by exhausting local opportunities and expanding into neighboring counties and states, identifying cash flow positive companies to acquire, and generally building shareholder value through accretive acquisitions and a tuck-in strategy to maximize free cash flow. To expand its national presence, NWMH plans on creating new satellite offices in order to become more customer-centric and operationally economical. In the next three to five years, NWMH plans to make an additional 12 to 20 acquisitions, representing approximately $40 to $65 million in revenue.

For more information, visit the company’s website at www.nationalwastemgmt.com

Posted in National Waste Management Holdings Inc. NWMH | Leave a comment

Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX) Files SEC Prospectus

Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX) on January 10, 2017, filed with the SEC a prospectus (http://dtn.fm/rU7Lh) for the sale in the aggregate of $33,842,512 of its common stock. The use of proceeds will be to fund both clinical and non-clinical studies of its product candidates and for general working capital.

Catalyst Pharmaceuticals is a development stage biopharmaceutical company which is developing CPP-115 to treat reduced GABAergic signaling-associated neurological conditions, such as Tourette’s and post-traumatic stress disorder. The FDA has designated CPP-115 orphan drug status in the U.S. for the treatment of infantile spasms. In Europe, for the treatment of West syndrome, it has been granted E.U. orphan medicinal product designation. In addition, the company is also developing a generic version of Sabril® (vigabatrin).

This prospectus offering is part of the company’s Shelf Registration Statement declared effective by the SEC on March 19, 2014. That enabled it to periodically sell its stock shares in the aggregate of $33,842,512, Catalyst Pharmaceuticals said in the new prospectus filing.

The company originally had 150 million shares of common stock and five million shares of preferred. Currently, it has 82,972,316 shares of common outstanding and no preferred shares outstanding.

The company expects to report to the FDA top line results in the second half of 2017 for its second phase 3 trial evaluating its candidate drug Firdapse® for the treatment of Lambert-Eaton Myasthenic Syndromes (LEMS). If the results are successful, the company expects to resubmit an NDA for Firdapse for the treatment of LEMS.

Further, if those test results are successful, the company expects to additionally provide evidence that Firdapse treats certain types of Congenital Myasthenic Syndromes (CMS) and request that CMS be included in its initial label.

Catalyst Pharmaceuticals, Inc., may also evaluate that drug for the treatment of myasthenia gravis and other rare neuromuscular diseases. No clinical programs for these indications have yet been developed, the company stated in the prospectus.

For CPP-115, the company intends to develop the drug for the treatment of epilepsy and Tourette’s syndrome. It would perform the required studies, subject to funding availability.

For more information, visit www.CatalystPharma.com

Posted in Small Cap News | Leave a comment

eXp World Holdings, Inc. (EXPI) Still Growing Despite the 2016 Drop in Housing Affordability

At the end of 2016, the Federal Reserve announced that it would be raising its key interest rate for the first time since the housing bubble burst between 2005 and 2006. According to an article on Realtor.com (http://dtn.fm/M08dy), the interest on a 30-year fixed rate mortgage is expected to grow from under 4.2% in 2016 to anywhere between 4.5% and 5% by the end of this year.

Despite the rise in home prices slowing, they are still expected to go up 4% in 2017. In addition, Realtor.com (http://dtn.fm/SaW2o) reported 12% less available homes for sale in November 2016 than in the previous year. Despite a shortage of homes on the market, the U.S. Commerce Department’s new residential sales report (http://dtn.fm/eC1Ww) stated that permits to put up new residences fell in November 2016. This was accompanied by fewer home constructions during the month, down nearly 20% below the revised October 2016 estimates. With the rise in mortgages and home prices, coupled with the low inventory of houses on the market today, buyers are expected to struggle to find their perfect homes.

Although the end of 2016 showed cause for concern for real estate businesses across the country, inventory for January moved at a 4% faster annual rate (http://dtn.fm/IhtZ6). This stronger than usual off-season has left a low volume of available homes for sale with very high prices. But this dip in volume has not halted the rising interest in eXp World Holdings, Inc. (OTCQB: EXPI), holding company of eXp Realty LLC, or its growth.

The agent-owned, cloud-based real estate brokerage has continued to see a significant rise in new agents and brokers, with a growth rate of over 100% thanks to its technology revenue sharing and ownership. The company has accepted over 100 new agents and brokers into its team in the month of February alone, leading to more virtual meetings with a significant growth in attendance.

The company’s stock price has been powering higher for the best part of two years, reaching $3.96 per share in afternoon trading on Tuesday. EXPI recently announced the addition of its newest team member, real estate veteran and former quarterback for the Los Angeles Rams Vince Ferragamo.

For more information, visit the company’s website at www.eXpWorldHoldings.com

Posted in eXp World Holdings, Inc. EXPI | Leave a comment

Monaker Group, Inc. (MKGI) Offers Business and Leisure Travelers Specialized Travel Tools with Maupintour

Maupintour (www.maupintour.com), a specialized tour operator owned by Monaker Group, Inc. (OTCQB: MKGI), is a hidden gem for both Monaker and its users. Maupintour, founded by Tom Maupin, designs comprehensive and creative tours for groups and individuals, offering travelers the opportunity to arrange uniquely customized tours to exotic locales. Other travel companies have booking engines that can arrange business travel, but Monaker has the unique advantage of owning a subsidiary, Maupintour, which designs specialized tours for the business traveler seeking to turn a business trip into a customized leisure adventure.

According to a 2016 Global Business Travel Association Index study (http://dtn.fm/iZ8rA), 45% of business travelers at firms with 1-249 employees extend their trips to combine business and leisure travel. Especially for younger travelers, extending company paid travel with additional days of personal travel offers them the chance to explore destinations they have already reached. Monaker’s booking engine is perfect for them to integrate the booking of business and leisure travel using the company’s efficient NextTrip.com site. For Monaker, Maupintour represents an important additional revenue stream.

To high-tech travelers, Monaker Group’s Maupintour is something very special. This 65-year-old tour arm of the company specializes in tailored tours to travelers who are adventurous and curious to try exotic trips. A business trip to Athens, Greece, can become a Maupintour archeology tour. A business meeting in Rome can become a specialized tour of the Vatican. A meeting in Chile can be extended and turned into a customized wine-tasting tour. A ho-hum business trip to a foreign location can become, by extension, an economical but glorious leisure trip, as well.

The Index study found that these travelers would use leisure travel not only to explore these destinations, but also to visit family and friends. In addition, it found that learning about a destination’s cultural offerings was important to these employees.

Monaker Group is a technology-focused company that is travel-driven, targeting the alternative lodging market (ALM). Bill Kerby, founder, chairman, and CEO of Monaker, sees ALR as one of the fastest expanding sectors of the entire travel market, projected by industry experts to reach $169 billion by 2019.

The company’s real-time booking engine offers ALR inventory, plus access to air, conventional lodging, business travel needs, and a library of greater than 15,000 video clips of destinations and leisure activities, cruises, and other travel, all on one site.

For more information, visit www.MonakerGroup.com

Posted in Monaker Group Inc. MKGI | Leave a comment

Annual Market Review Reveals OTC Markets Have Come of Age

After a century of service providing quotes on stocks and bonds to investors around the world, the OTC markets have come of age, and the recently published Annual Markets Review (http://dtn.fm/IW0iC) from OTC Markets Group, Inc. (OTCQX: OTCM) reveals that maturity. The company’s over-the-counter (OTC) platforms now host some 9,620 U.S. and global securities that generate an annual trading dollar volume of around $193 billion. Its OTCQX Best Market and OTCQB Venture Market provide price and liquidity information on some of the world’s best companies, and over 100 broker-dealers play an active part as market-makers. For companies, both big and small, being quoted on the OTC markets makes being public decidedly less painful.

The current tiered market structure makes it easier for companies to demonstrate their financial and corporate governance standards and to provide current information, avoiding the trading hurdles due to the opacity associated with the old pink sheets. The almost 10,000 securities included in the OTC Markets quotation system are organized into three markets, OTCQX, OTCQB, and Pink, to better inform investors.

The OTCQX Best Market is the premier quotation platform. To be quoted on the OTCQX market, a company must meet high financial standards, follow best practice corporate governance, demonstrate compliance with U.S. securities laws, and have a professional third-party sponsor introduction. Penny stocks, shell companies and companies in bankruptcy cannot qualify for OTCQX. The companies whose securities appear on the OTCQX are distinguished by the integrity of their operations and the diligence with which they convey their qualifications. The OTCQX Best Market, which welcomed some 50 new companies in 2016, offers transparent and efficient trading… without the cost and complexity of a U.S. exchange listing.

The OTCQB Venture Market is meant for early-stage and developing U.S. and international companies that are not yet able to qualify for OTCQX. To be eligible, a company must be current in its reporting and undergo an annual verification and management certification process. It must, also, meet a $0.01 bid test and may not be in bankruptcy. In 2016, 230 new companies joined the platform.

The Pink Open Market approximates most closely to the traditional pink sheets, although a particular market tier classification is not an indication of either the value of the security or an endorsement (or not) of the issuer. Market tiers are based only on the quality and timeliness of the information provided. OTCQB Venture Market and Pink Open Market quotes may be of securities for companies of high quality, as well as of those for speculative, distressed, or questionable companies.

Since May 16, 2013, the U.S. Securities and Exchange Commission (SEC) has considered the OTCQB and OTCQX marketplaces to be public marketplaces for purposes of establishing a public market price when registering securities for resale in equity line financings.

During 2016, the OTC Markets Group platforms passed some memorable milestones. Some 280 new companies made their debut on the OTCQX and OTCQB markets. In particular, the OTCQX shone under the spotlight: the OTCQX Best 50 companies (http://dtn.fm/0XznV) delivered an average total return of 130 percent compared to the S&P 500, which went up by 9.5 percent in 2016.

Twenty U.S. states now recognize the OTC markets for the purposes of their Blue Sky Manual Exemptions. Blue Sky laws are U.S. state securities laws designed to protect the public from securities fraud. The aim is to achieve Blue Sky recognition from all 50 states. In addition, seven share transfer agents participate in a new program that makes current verified information available to the public.

Client companies are voicing their approval of the measures to improve the OTC markets. As global information services giant Experian plc explained:

“…OTCQX offered a liquid trading platform for our ADRs, enabling US investors to invest directly in Experian stock via a US traded instrument, but it did not require us to list on a US exchange or register with the SEC. As a result, we continue to comply with the regulation and governance requirements of our primary London listing and are not subject to onerous duplicate regulation and governance requirements by virtue of our ADRs being traded in the US.”

It looks like the OTC Markets have definitely come of age by making being public much less painful.

For more information, please visit www.OTCMarkets.com

Posted in Small Cap News | Leave a comment

IntelliPharmaCeutics International, Inc. (NASDAQ: IPCI) Abuse Deterrent Technology featured at Healthcare Conference

The ‘2017 Disruptive Growth & Healthcare Conference’, which ran February 15-16 at the Convene at 730 Third Avenue Conference Center in midtown Manhattan, New York, featured some stellar participants, either as presenters or as sponsors. Along with over 60 other firms in a variety of fields related to biotech, IntelliPharmaCeutics International, Inc. (NASDAQ: IPCI) (TSX: I) was on the bill. The Toronto, Ontario-based company was scheduled to introduce its drug delivery technologies and exhibit its leading pipeline candidates.

The ‘2017 Disruptive Growth & Healthcare Conference’ hosted by RHK Capital, which formerly operated as Source Capital Group, was sponsored by leading investor relations and financial services firms, including NetworkNewsWire, a Platinum Sponsor.

With its drug delivery technologies built on the Hypermatrix™ platform, IPCI is targeting billion dollar markets. The company’s extended release (ER) (XR) formulations provide mechanisms to slowly dissolve and release constant amounts of a medication over time. Instead, of a patient having to take a pill three times a day, with the risk of losing count or forgetting, one daily dose will improve efficacy. Closer compliance with prescription rules results in better therapy.

ER formulations, widespread for leading indications, are expanding to new drugs. Medications that benefit from the IPCI technology include Oxycodone XR, Dexmethylphenidate ER, Venlafaxine ER, Desvenlafaxine ER, Levetiracetam ER, Lamotrigine ER and Pregabalin. Together, these pharmaceuticals present a market opportunity that exceeds $9 billion.

But a bigger prize is the market for abuse deterrent formulations (ADF), which attempt to fight prescription drug abuse by increasing the difficulty of inappropriate use of opioid medications. In the U.S., opioid abuse is on the rise. Data published by the American Society of Addiction Medicine reveals that in 2015 there were 21,101 deaths caused by opioid overdose. Opioids include licit substances such as codeine, fentanyl, hydrocodone and oxycodone, and illicit ones such as heroin and opium. This is a market estimated to be about $60 billion.

Apart from having its eye on these two lucrative opportunities, IPCI has a growing pipeline of new candidates that may lead to New Drug Application (NDA) and Abbreviated New Drug Application (ANDA) filings. An NDA is filed when a sponsor believes there is enough evidence on a new drug’s safety and effectiveness to support FDA approval to bring it to market. An ANDA is required for generic drugs that are bioequivalent to a drug already being marketed.

IPCI has two novel NDA candidates, Rexista® and Regabatin XR™. Earlier this month, the company announced it had filed a New Drug Application (NDA) seeking authorization to market its Rexista™ abuse-deterrent oxycodone hydrochloride extended release tablets in the 10 mg, 15 mg, 20 mg, 30 mg, 40 mg, 60 mg and 80 mg strengths.

The FDA has determined that the company’s application is sufficiently complete to permit a substantive review, and has set a target action date under the Prescription Drug User Fee Act (PDUFA) of September 25, 2017. IPCI was able to demonstrate that Rexista™ is bioequivalent to OxyContin® (oxycodone hydrochloride extended release). With this upcoming milestone, IPCI will be setting another marker on its journey to success.

Founded in 1998 by the husband and wife team of Dr. Isa Odidi and Dr. Amina Odidi, IPCI has come a long way. The company now specializes in the research, development and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs. Its patented Hypermatrix™ technology is a multidimensional controlled-release drug delivery platform that can be applied to the efficient development of a wide range of existing and new pharmaceuticals.

Based on this technology platform, Intellipharmaceutics has developed several drug delivery systems and a pipeline of products in therapeutic areas that include neurology, cardiovascular, gastrointestinal tract, diabetes and pain.

For more information, visit www.Intellipharmaceutics.com

Posted in Small Cap News | Leave a comment

The Diversification of Auxilio, Inc. (AUXO)

Auxilio, Inc. (NYST MKT: AUXO) is one of a select number of businesses headquartered in Mission Viejo, a mainly residential city in Orange County, California, and a closer look at this small yet booming business shows that it is unique not only for where its offices are based, but also for its value proposition.

Auxilio offers managed print services exclusively to the U.S. health care industry. A leader in this sector due to its innovative and customer-driven approach, Auxilio takes full responsibility for its health care clients’ on-site print environment through situation assessment, process analysis, strategy development and program implementation. The company also works closely with hospitals and hospital systems to deliver quality patient care and accomplishes this objective by providing a customized, scalable document solutions strategy that analyzes, remediates and manages document and print workflows from start to finish.

A vendor-independent company, Auxilio provides intelligent solutions, a risk-free program and guaranteed savings. It assumes all costs related to the print business environment by customizing, streamlining and seamlessly integrating its services at predictable fixed rates that are unmatched in the industry. As a result, its print management programs drive out costs, increase employee productivity and exceed patient care standards, and the hospitals and health systems that work with the company benefit from its streamlined and aligned processes and infrastructure.

For over 10 years, more than 200 of the leading hospitals and health systems in the U.S. have turned to Auxilio to resolve their broken document and digital workflow processes, and its document solutions have helped them reduce waste, safeguard protected health information (PHI) and improve operational efficiency while driving incredible cost savings. The company consistently delivers for its clients by leveraging its three core services lines: Managed Print Services, Document Consulting and iPLATFORM, an intelligent workflow automation suite.

According to the Orange County Business Journal’s 2016 Special Report (http://dtn.fm/C0x5k), from 2014 to 2016, Auxilio clocked more than 40% in growth, making it one of the fastest-growing public companies in the Orange County area. During this time, the company grew its existing business by continuously delivering excellent customer service, and it diversified into cyber security by acquiring two information technology security firms. The resulting demand for Auxilio’s cyber security services and rapid adoption of its Managed Print Services program by many large health care institutions contributed significantly to its recent swift growth.

For more information, visit www.AuxilioInc.com

Posted in Small Cap News | Leave a comment